What is JBIO's warrant liability related party?

JBIO (JBIO) reported warrant liability related party of $2.67M in Q1 2026.

What does warrant liability related party mean?

This represents the fair value of derivative financial instruments issued to related parties that grant the holder the right to purchase company stock at a specified price. Because these liabilities are often marked-to-market, changes in the valuation can introduce volatility into the company's financial statements. It serves as an indicator of potential future dilution and the financial structure of capital raised from insiders.

JBIO JBIO Warrant Liability Related Party

Warrant Liability Related Party at other companies

Zevra Therapeutics, Inc.ZVRA

$9.58M-46.2%

Archer AviationACHR

$7.1M-85.1%

Intuitive Machines, Inc.LUNR

$69.82M+171%

SatellogicSATL

$31.64M+112%

Life360, Inc.LIF

$0-100%

SHA

SharonAI Holdings, Inc. Class A Common StockSHAZ

$6.68K—

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept ck0001798749:WarrantLiabilityRelatedParty.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's warrant liability related party.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's warrant liability related party?: JBIO (JBIO) reported warrant liability related party of $2.67M in Q1 2026.
What does warrant liability related party mean?: This represents the fair value of derivative financial instruments issued to related parties that grant the holder the right to purchase company stock at a specified price. Because these liabilities are often marked-to-market, changes in the valuation can introduce volatility into the company's financial statements. It serves as an indicator of potential future dilution and the financial structure of capital raised from insiders.